Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Pacific Edge Limited ( (PFGTF) ) has issued an update.
Pacific Edge Limited has announced a NZ$20 million capital raise to support its operations and strategic objectives. The funds will be used to extend cash reserves, accelerate the adoption of its Triage product in the US, and regain Medicare coverage for its tests. This capital injection aims to sustain the company’s growth momentum and support product innovation, particularly in international markets, while addressing the recent loss of Medicare coverage.
More about Pacific Edge Limited
Pacific Edge Limited is a cancer diagnostics company that specializes in developing and commercializing diagnostic tests for the early detection and management of cancer. The company focuses on providing innovative solutions in the oncology sector, with a particular emphasis on non-invasive bladder cancer tests.
Learn more about PFGTF stock on TipRanks’ Stock Analysis page.